| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/29/1997 | US5652126 Use of restriction endonuclease sequences for cleaving phosphorothioate oligonucleotides |
| 07/29/1997 | US5652125 Process for preparing daunorubicin |
| 07/29/1997 | US5652123 Protein having interleukin 13 activity, recombinant DNA coding for this protein, transformed cells and microorganisms |
| 07/29/1997 | US5652122 Nucleic acids encoding and methods of making tat-derived transport polypeptides |
| 07/29/1997 | US5652120 Gene coding human epidermal growth factor and process for preparing the same |
| 07/29/1997 | US5652119 Recombinant feline herpesvirus vaccine |
| 07/29/1997 | US5652116 Method for genetically manipulating peptide synthetases |
| 07/29/1997 | US5652113 Contacting nonneuronal cells expressing on their cell surface the human serotonin receptor with chemical compound under conditions suitable for binding, detecting specific binding of compound to receptor |
| 07/29/1997 | US5652112 Assay for type I collagen carboxy-terminal telopeptide analytes |
| 07/29/1997 | US5652110 Antibodies to αvβ3 integrin |
| 07/29/1997 | US5652109 Antitumor agents; medical diagnosis |
| 07/29/1997 | US5652107 Diagnostic assays and kits for RNA using RNA binary probes and a ribozyme ligase |
| 07/29/1997 | US5652105 Substrate for detection of mammalian 5-C-DNA methyltransferase |
| 07/29/1997 | US5652103 Method for sequencing synthetic oligonucleotides containing non-phosphodiester internucleotide linkages |
| 07/29/1997 | US5652100 Stably transfected rodent fibroblast cell lines expressing human GABA-A -receptors |
| 07/29/1997 | US5652095 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 07/29/1997 | US5652094 Nucleozymes |
| 07/29/1997 | US5652092 Amyloid precursor proteins and method of using same to assess agents which down-regulate formation of β-amyloid peptide |
| 07/29/1997 | US5651992 In vitro activation of human fetal cells |
| 07/29/1997 | US5651981 Cationic phospholipids for transfection |
| 07/29/1997 | US5651972 Use of recombinant swine poxvirus as a live vaccine vector |
| 07/29/1997 | US5651964 Transfection, gene expression, antitumor, anticarcinogenic |
| 07/29/1997 | US5651963 Heterodimers forms of CSF-1 and pharmaceutical compositions thereof |
| 07/29/1997 | CA1339188C Removal of protein a from antibody preparations |
| 07/29/1997 | CA1339113C Family of xanthan-based polysaccharide polymers including non-acetylatedand/or non-pyruvylated gum and acetylated or non-acetylated polytetramergum |
| 07/29/1997 | CA1339107C 2,5-diketogluconic acid reductase purification and use in ascorbic acid production |
| 07/29/1997 | CA1339106C Hirullin polypeptides having anticoagulant activity |
| 07/29/1997 | CA1339105C Modified proteins |
| 07/29/1997 | CA1339104C Hirudin derivative |
| 07/29/1997 | CA1339103C Stable creatine amidinohydrolase mutants |
| 07/29/1997 | CA1339102C Dna molecules useful in plant protection |
| 07/29/1997 | CA1339101C Production of guar alpha-galactosidase and immunologically related alpha-galactosidases by host organisms transformed with recombinant dna methods |
| 07/29/1997 | CA1339100C Molecular cloning and expression of genes encoding proteolytic enzymes |
| 07/29/1997 | CA1339099C Yeast vector |
| 07/29/1997 | CA1339098C Characterization and detection of sequences associated with autoimmune diseases |
| 07/29/1997 | CA1339097C Performing nucleic acid reactions |
| 07/29/1997 | CA1339096C Novel one step method and polynucleotide compounds for hybridizing to target polynucleotides |
| 07/24/1997 | WO1997026535A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | WO1997026523A2 Detection of a leptin receptor variant and methods for regulating obesity |
| 07/24/1997 | WO1997026372A1 Diagnostic test to determine the malignancy of smooth muscle tumors |
| 07/24/1997 | WO1997026370A1 Leptin receptor variants |
| 07/24/1997 | WO1997026368A1 Process for the amplification of nucleic acid |
| 07/24/1997 | WO1997026366A1 Anthranilate synthase gene and use thereof |
| 07/24/1997 | WO1997026365A2 Transgenic maize with increased mannitol content |
| 07/24/1997 | WO1997026364A1 Method of inhibiting mycotoxin production in seed crops by modifying lipoxygenase pathway genes |
| 07/24/1997 | WO1997026363A2 Method of inducing nitrogen fixation in plants |
| 07/24/1997 | WO1997026362A1 Nucleic acid molecules from plants coding enzymes which participate in the starch synthesis |
| 07/24/1997 | WO1997026361A2 Bacterial donor cell useful in conjugation |
| 07/24/1997 | WO1997026360A1 Novel methods for the characterization of compounds which stimulate stf-1 expression in pancreatic islet cells |
| 07/24/1997 | WO1997026359A1 System for the expression of heterologous antigens as fusion proteins |
| 07/24/1997 | WO1997026358A1 Compositions and methods for modulating cell proliferation using growth factor-polysaccharide binding fusion proteins |
| 07/24/1997 | WO1997026357A1 Methods and compositions for inhibiting hexokinase |
| 07/24/1997 | WO1997026356A1 PHENYLALANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026355A1 NOVEL VALYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026354A1 HISTIDYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026353A1 ALANYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026352A1 STAPHYLOCOCCUS AUREUS SERYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026351A1 STAPHYLOCOCCUS AUREUS TYROSYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026350A1 STAPHYLOCOCCUS AUREUS METHIONYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026348A1 ASPARAGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026347A1 ARGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026345A1 GLUTAMYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026343A1 NOVEL PROLYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026341A1 CYSTEINYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026340A1 STAPHYLOCOCCUS AUREUS GLYCYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026339A1 Method of protecting crop plants against insect pests |
| 07/24/1997 | WO1997026338A1 Staphylococcus aureus wcuh29 spoiiie protein |
| 07/24/1997 | WO1997026337A1 Methods for delivering dna to muscle cells using recombinant adeno-associated virus virions |
| 07/24/1997 | WO1997026336A1 Compositions for treating anemia |
| 07/24/1997 | WO1997026335A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | WO1997026334A1 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | WO1997026333A1 Humanized green fluorescent protein genes and methods |
| 07/24/1997 | WO1997026332A1 Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists |
| 07/24/1997 | WO1997026331A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 07/24/1997 | WO1997026330A2 Morphological mutants of filamentous fungi |
| 07/24/1997 | WO1997026328A1 Immunotherapy using cytotoxic t lymphocytes (ctl) |
| 07/24/1997 | WO1997026327A1 Compositions and methods for mediating cell cycle progression |
| 07/24/1997 | WO1997026326A1 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use |
| 07/24/1997 | WO1997026325A1 Compositions and their uses for transfer of down-regulatory genes into cells associated with inflammatory responses |
| 07/24/1997 | WO1997026321A2 Recombinant expression of proteins from secretory cell lines |
| 07/24/1997 | WO1997026320A2 Product for inhibition of attachment of h. influenzae to human cells |
| 07/24/1997 | WO1997026318A1 Soaps produced from high laurate canola oil-based fatty acids |
| 07/24/1997 | WO1997026275A1 Protein occlusion for delivery of small molecules |
| 07/24/1997 | WO1997026272A1 Leptin receptor variants |
| 07/24/1997 | WO1997026270A2 Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules |
| 07/24/1997 | WO1997026268A2 A process for inhibiting smooth muscle cell proliferation and motility |
| 07/24/1997 | WO1997026245A1 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes |
| 07/24/1997 | WO1997026071A1 The use of an earlier known separation material and novel forms of the material |
| 07/24/1997 | WO1997026013A1 Obesity protein formulations |
| 07/24/1997 | WO1997026010A1 Anticoagulant agents useful in treatment of thrombosis |
| 07/24/1997 | WO1997026006A1 Compositions and methods for administering borrelia burgdorferi antigens |
| 07/24/1997 | WO1997026000A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | WO1997025861A1 H2-m modified transgenic animals |
| 07/24/1997 | WO1997025860A1 Cellular immunogens useful as cancer vaccines |
| 07/24/1997 | WO1997022703A3 Novel starches via modification of expression of starch biosynthetic enzyme genes |
| 07/24/1997 | WO1997018308A3 K-atp channel protein and methods relating to it |